Francisco Cartujano-Barrera1, Evelyn Arana-Chicas2, Delwyn Catley3, Lisa Sanderson Cox4, Francisco J Diaz5, Edward F Ellerbeck4, Kristi D Graves6, Chinwe Ogedegbe7, Ana Paula Cupertino2. 1. James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America. Electronic address: Francisco_Cartujano@URMC.Rochester.edu. 2. James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America. 3. Center for Children's Healthy Lifestyles & Nutrition, Children's Mercy Kansas City, Kansas City, MO, United States of America. 4. Department of Population Health, University of Kansas Medical Center, Kansas City, KS, United States of America. 5. Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, United States of America. 6. Department of Oncology, Georgetown University, Washington, D.C., United States of America. 7. Emergency and Trauma Center, Hackensack University Medical Center, Hackensack, NJ, United States of America.
Abstract
INTRODUCTION: Latinos, the largest minority group in the U.S., experience tobacco-related disparities, including limited access to cessation resources. Evidence supports the efficacy of mobile interventions for smoking cessation, which may be greater among Latinos, the highest users of text messaging. OBJECTIVES: To describe the methodology of a randomized clinical trial to evaluate the impact of Decídetexto, a culturally appropriate mobile smoking cessation intervention versus standard care on smoking abstinence (cotinine-verified 7-day point prevalence abstinence) at Month 6 among Latino smokers. METHODS:Latino smokers (N = 618) will be randomized to one of two conditions: 1) Decídetexto or 2) standard of care. Decídetexto is a mobile smoking cessation intervention (available in English and Spanish) that incorporates three integrated components: 1) a tablet-based software that collects smoking-related information to develop an individualized quit plan, 2) a 24-week text messaging counseling program with interactive capabilities, and 3) pharmacotherapy support. Decídetexto follows the Social Cognitive Theory as theoretical framework. Standard of care consists of printed smoking cessation materials along with referral to telephone quitline. Participants in both groups are given access to free pharmacotherapy (nicotine patches or gum) by calling study phone number. Promotores de Salud will rely on community-based approaches and clinical settings to recruit smokers into the study. All participants will complete follow-up assessments at Week 12 and Month 6. DISCUSSION: If successful, Decídetexto will be ready to be implemented in different community- and clinic-based settings to reduce tobacco-related disparities.
RCT Entities:
INTRODUCTION: Latinos, the largest minority group in the U.S., experience tobacco-related disparities, including limited access to cessation resources. Evidence supports the efficacy of mobile interventions for smoking cessation, which may be greater among Latinos, the highest users of text messaging. OBJECTIVES: To describe the methodology of a randomized clinical trial to evaluate the impact of Decídetexto, a culturally appropriate mobile smoking cessation intervention versus standard care on smoking abstinence (cotinine-verified 7-day point prevalence abstinence) at Month 6 among Latino smokers. METHODS: Latino smokers (N = 618) will be randomized to one of two conditions: 1) Decídetexto or 2) standard of care. Decídetexto is a mobile smoking cessation intervention (available in English and Spanish) that incorporates three integrated components: 1) a tablet-based software that collects smoking-related information to develop an individualized quit plan, 2) a 24-week text messaging counseling program with interactive capabilities, and 3) pharmacotherapy support. Decídetexto follows the Social Cognitive Theory as theoretical framework. Standard of care consists of printed smoking cessation materials along with referral to telephone quitline. Participants in both groups are given access to free pharmacotherapy (nicotine patches or gum) by calling study phone number. Promotores de Salud will rely on community-based approaches and clinical settings to recruit smokers into the study. All participants will complete follow-up assessments at Week 12 and Month 6. DISCUSSION: If successful, Decídetexto will be ready to be implemented in different community- and clinic-based settings to reduce tobacco-related disparities.
Authors: A Paula Cupertino; Kimber Richter; Lisa Sanderson Cox; Susan Garrett; Rigoberto Ramirez; Fernando Mujica; Edward F Ellerbeck Journal: J Health Care Poor Underserved Date: 2010-05
Authors: Arnold H Levinson; Eliseo J Pérez-Stable; Paula Espinoza; Estevan T Flores; Tim E Byers Journal: Am J Prev Med Date: 2004-02 Impact factor: 5.043
Authors: Arnold H Levinson; Evelinn A Borrayo; Paula Espinoza; Estevan T Flores; Eliseo J Pérez-Stable Journal: Am J Prev Med Date: 2006-06-05 Impact factor: 5.043
Authors: Ana Paula Cupertino; Francisco Cartujano-Barrera; Jaime Perales; Taynara Formagini; Rosibel Rodríguez-Bolaños; Edward F Ellerbeck; Guadalupe Ponciano-Rodríguez; Luz Myriam Reynales-Shigematsu Journal: Telemed J E Health Date: 2018-07-26 Impact factor: 3.536
Authors: Robert C Kaplan; Shrikant I Bangdiwala; Janice M Barnhart; Sheila F Castañeda; Marc D Gellman; David J Lee; Eliseo J Pérez-Stable; Gregory A Talavera; Marston E Youngblood; Aida L Giachello Journal: Am J Prev Med Date: 2014-05 Impact factor: 5.043
Authors: Francisco Cartujano-Barrera; Evelyn Arana-Chicas; Mariana Ramírez-Mantilla; Jaime Perales; Lisa Sanderson Cox; Edward F Ellerbeck; Delwyn Catley; Ana Paula Cupertino Journal: Patient Prefer Adherence Date: 2019-07-22 Impact factor: 2.711
Authors: Ana Paula Cupertino; Francisco Cartujano-Barrera; Mariana Ramírez; Rosibel Rodríguez-Bolaños; James F Thrasher; Gloria Pérez-Rubio; Ramcés Falfán-Valencia; Edward F Ellerbeck; Luz Myriam Reynales-Shigematsu Journal: JMIR Mhealth Uhealth Date: 2019-04-25 Impact factor: 4.773
Authors: Evelyn Arana-Chicas; Francisco Cartujano-Barrera; Katherine K Rieth; Kimber K Richter; Edward F Ellerbeck; Lisa Sanderson Cox; Kristi D Graves; Francisco J Diaz; Delwyn Catley; Ana Paula Cupertino Journal: J Med Internet Res Date: 2022-06-27 Impact factor: 7.076
Authors: Francisco Cartujano-Barrera; Lisa Sanderson Cox; Delwyn Catley; Zainab Shah; Ash B Alpert; Ana Paula Cupertino Journal: Explore (NY) Date: 2021-11-17 Impact factor: 2.358
Authors: Nan Jiang; Erin S Rogers; Paula Cupertino; Xiaoquan Zhao; Francisco Cartujano-Barrera; Joanne Chen Lyu; Lu Hu; Scott E Sherman Journal: JMIR Form Res Date: 2022-06-30
Authors: Francisco Cartujano-Barrera; Cristina I Peña-Vargas; Evelyn Arana-Chicas; José G Pérez-Ramos; Josiemer Mattei; Alejandra Hurtado-de-Mendoza; Rosario Costas-Muñiz; Julio Jiménez; Ana Paula Cupertino; Eida M Castro Journal: Int J Environ Res Public Health Date: 2021-02-03 Impact factor: 3.390
Authors: Francisco Cartujano-Barrera; Ruthmarie Hernández-Torres; Rafael H Orfin; Arlette Chávez-Iñiguez; Olga Alvarez Lopez; Chiamaka Azogini; Diana Bermudez; Evelyn Arana-Chicas; Xueya Cai; Scott McIntosh; Deborah J Ossip; Ana Paula Cupertino Journal: Children (Basel) Date: 2022-06-22
Authors: Francisco Cartujano-Barrera; Ruthmarie Hernández-Torrez; Xueya Cai; Rafael H Orfin; Chiamaka Azogini; Arlette Chávez-Iñiguez; Edgar Santa Cruz; Maansi Bansal-Travers; Karen M Wilson; Scott McIntosh; Deborah J Ossip; Ana Paula Cupertino Journal: Int J Environ Res Public Health Date: 2022-08-14 Impact factor: 4.614